5-Gate Safe-by-Design (SSbD) Preclinical Stage-Gate Roadmap

Sequential Formulation Checkpoints & Early-Gate Remediation Protocols

Safe-by-Design nanomedicine translation enforces five sequential go/no-go checkpoints: synthesis impurity locking, orthogonal endotoxin clearance, hemolysis and CARPA complement triage, single-cell PBMC immunotoxicity below 10 cm2/mL, and GLP extractables packaging. Failing Gate 02 or Gate 03 triggers targeted purification or surface-PEG remodeling rather than discarding promising active payloads.

Synthesized from EU NanoSafety Cluster SSbD principles and NCI-NCL translational go/no-go criteria.

1. Five-Step Preclinical Translation Stepper

GATE 01
Impurity & PCC

Synthesis Purification & 3-Descriptor Locking (EUNCL-PCC-01)

Quantify residual metal catalysts via ICP-MS, lock DLS PDI (< 0.25), zeta potential, C:O ratio, and BET specific surface area before biological dilution.
GATE 02
Endotoxin

Orthogonal Pyrogen & Spike-Recovery Gate (ISO 29701)

Confirm 50% to 150% positive product recovery across serial dilutions; verify < 0.5 EU/mL using rFC or TNF-alpha polymyxin B inhibitor controls when LAL quenches.
GATE 03
Hemocompatibility

Hemolysis & Complement CARPA Triage (NCL ITA-5.1)

Pass ASTM F756 hemolysis (< 5%) and verify human plasma SC5b-9 / C3a remains < 2x vehicle baseline prior to intravenous escalation.
GATE 04
Immune Panel

Single-Cell Macrophage & PBMC Polarization (EUNCL-ITA-05)

Dose below 10.0 cm2/mL BET surface area across >= 3 human donors; audit M1/M2 markers, dendritic CD80/CD86 maturation, and T-cell viability.
GATE 05
IND / EMA

GLP Toxicology & ISO 10993-12 Dossier Packaging

Compile batch certificates, 72h extractables profiles for scaffolds/biosensors, and PK/biodistribution bridging files for regulatory review.

2. Gate-Failure Remediation Matrix

Failed Gate	Root Cause Indicator	Engineering Remediation Path	Re-Test Gate
Gate 01 Failure	PDI > 0.30 or trace Ti/Fe catalyst > 50 ppm	Cup-horn sonication + tangential flow filtration (TFF) dialysis	Re-run PCC-01
Gate 02 Failure	TNF-alpha abolished by polymyxin B (true LPS)	Replace synthesis water with WFI; re-synthesize in depyrogenated glass	Discard Batch
Gate 03 Failure	SC5b-9 surge > 3x baseline in human plasma	Reduce surface amine density or modulate PEG chain length (2k vs. 5k)	Re-run ITA-5.1
Gate 04 Failure	NLRP3 IL-1beta spike with lateral flakes > 1 um	Fractionate sheet width below 400 nm via density gradient centrifugation	Re-run ITA-05

3. Gate Failure Remediation Selector

GATE 02 REMEDIATION : PYROGEN VS INTRINSIC

Polymyxin B Suppresses TNF-alpha: Confirmed Batch Endotoxin

Do not progress to animal PK. Heat-inactivating or autoclaving cannot rescue endotoxin-contaminated batches; re-synthesize precursors in depyrogenated borosilicate vessels using WFI.